NLM Digital Collections

Search

Start Over Subjects Emergencies ✖Remove constraint Subjects: Emergencies Subjects Public Health ✖Remove constraint Subjects: Public Health

1. Legislative priorities for the 116th Congress

Publication:
Washington, DC : Trust for America's Health, January 2019
Subject(s):
Public Health
Chronic Disease -- prevention & control
Climate Change
Disease Outbreaks -- prevention & control
Emergencies
Financing, Government
Global Health
Health Promotion
Preventive Health Services
Substance-Related Disorders -- prevention & control
Suicide -- prevention & control
Humans
United States

2. Emergency use authorization of medical products and related authorities: guidance for industry and other stakeholders

Publication:
Silver Spring, MD : Food and Drug Administration, U.S. Department of Health and Human Services, January 2017
Subject(s):
Civil Defense -- legislation & jurisprudence
Device Approval
Drug Approval
Emergencies
Terrorism
Emergency Medical Services
Equipment Safety
Off-Label Use
Public Health
Safety
Humans
United States
United States. Department of Health and Human Services.
United States. Department of Homeland Security.
United States. Food and Drug Administration.

3. Ready or not?: protecting the public's health from diseases, disasters, and bioterrorism : 2011

Author(s):
Levi, Jeffrey, author
Segal, Laura M., author
Lieberman, Dara Alpert, author
St. Laurent, Rebecca, author
Publication:
Washington, DC : Trust for America's Health, December 2011
Subject(s):
Bioterrorism -- prevention & control
Civil Defense -- organization & administration
Disaster Planning -- organization & administration
Disasters -- prevention & control
Disease Outbreaks -- prevention & control
Emergencies
Public Health
Biosurveillance
Budgets
Emergency Medical Services
Epidemics -- prevention & control
Financing, Government
Food Safety
Interinstitutional Relations
Local Government
State Government
Vaccines
Weapons of Mass Destruction
Humans
United States
United States. Department of Homeland Security
Centers for Disease Control and Prevention (U.S.)

4. Smallpox (variola virus) infection: developing drugs for treatment or prevention

Publication:
Silver Spring, MD : Center for Drug Evaluation and Research, November 2019
Subject(s):
Clinical Trials as Topic
Drug Development -- standards
Smallpox -- drug therapy
Smallpox -- prevention & control
Antiviral Agents -- pharmacology
Antiviral Agents -- therapeutic use
Drug Evaluation, Preclinical
Emergencies
Investigational New Drug Application
Models, Animal
Orthopoxvirus
Public Health
Research Design
Safety
Toxicity Tests
Variola virus
Animals
Humans
United States
United States. Department of Health and Human Services.
United States. Food and Drug Administration.